DePrince Race & Zollo Inc (DRZ)’s Quest Diagnostics DGX Stock Holding History

DePrince Race & Zollo Inc (DRZ)’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-110,206	Closed	-$14.7M	–	197
2022 Q2	$14.7M	Sell	110,206 -75,228	-41%	-$10.3M	0.34%	117
2022 Q1	$25.4M	Sell	185,434 -469	-0.3%	-$65.4K	0.49%	101
2021 Q4	$32.2M	Sell	185,903 -31,949	-15%	-$4.86M	0.82%	44
2021 Q3	$31.7M	Sell	217,852 -15,005	-6%	-$2.2M	0.85%	31
2021 Q2	$30.7M	Buy	232,857 +6,708	+3%	+$878K	0.78%	35
2021 Q1	$29M	Buy	226,149 +85,931	+61%	+$10.6M	0.78%	39
2020 Q4	$16.7M	Buy	140,218 +12,988	+10%	+$1.58M	0.53%	95
2020 Q3	$14.6M	Buy	+127,230	New	+$15M	0.55%	83

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DePrince Race & Zollo Inc (DRZ)'s DGX Position: Q3 2022 in Review

DePrince Race & Zollo Inc (DRZ) sold out of Quest Diagnostics (DGX) in Q3 2022, closing a stake of 110,206 shares — an estimated $14.7M sold.

DePrince Race & Zollo Inc (DRZ) first reported a position in DGX in Q3 2020 and held it in 8 quarters. The position peaked at $32.2M in Q4 2021. 809 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

DePrince Race & Zollo Inc (DRZ) reported no remaining Quest Diagnostics position as of Q3 2022 after selling out during the quarter.
DePrince Race & Zollo Inc (DRZ) sold 110,206 Quest Diagnostics shares in Q3 2022, an estimated $14.7M.
DePrince Race & Zollo Inc (DRZ) first reported a position in Quest Diagnostics in Q3 2020 and held it in 8 quarters.
DePrince Race & Zollo Inc (DRZ)'s Quest Diagnostics position peaked at $32.2M in Q4 2021.
809 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q3 2022, filed 14 Nov 2022.